Radiothérapie trifractionnée accélérée seule ou alternée avec la chimiothérapie chez des patients souffrant d’un cancer localement évolué de la sphère ORL : analyse de la toxicité tardive
- 1 April 2001
- journal article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 5 (2) , 130-137
- https://doi.org/10.1016/s1278-3218(01)00085-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and-IV carcinomas of the head and neckStrahlentherapie und Onkologie, 1998
- Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialRadiotherapy and Oncology, 1997
- A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancerRadiotherapy and Oncology, 1997
- Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factorsRadiotherapy and Oncology, 1995
- Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG 83-13International Journal of Radiation Oncology*Biology*Physics, 1995
- Randomized phase trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG 88-09International Journal of Radiation Oncology*Biology*Physics, 1995
- About tolerance and quality. An important notice to all radiation oncologistsRadiotherapy and Oncology, 1995
- Psychological distress in head and neck cancer patients 7-11 years after curative treatmentBritish Journal of Cancer, 1995
- Complications tardives des associations chimioradiothérapiques: aspects fondamentaux et expérience cliniqueBulletin du Cancer/Radiothérapie, 1995
- Lhermitte's sign: Incidence and treatment variables influencing risk after irradiation of the cervical spinal cordInternational Journal of Radiation Oncology*Biology*Physics, 1993